FDA Launching Drug Risk Communications Study for Social Media

Drug Industry Daily
A A
The FDA plans to examine if substantive risk information about a drug can be effectively communicated via character-limited social media platforms like Twitter or if just a link will do.

To View This Article:

Login

Subscribe To Drug Industry Daily